免疫力低下患者的感染预防：对法国现有组织机构的跨横向多中心调查。

IF 2.9 4区医学 Q2 INFECTIOUS DISEASES

Infectious diseases now Pub Date : 2024-02-09 DOI:10.1016/j.idnow.2024.104863

A. Saade , B. Wyplosz , M. Baldeyrou , C. Paris , P. Tattevin , C. Janssen , for the SPILF group “Vaccination et Prévention”

{"title":"免疫力低下患者的感染预防：对法国现有组织机构的跨横向多中心调查。","authors":"A. Saade , B. Wyplosz , M. Baldeyrou , C. Paris , P. Tattevin , C. Janssen , for the SPILF group “Vaccination et Prévention”","doi":"10.1016/j.idnow.2024.104863","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>To evaluate current organization of infection prevention for immunocompromised patients (ICP) at a countrywide level.</p></div><div><h3>Methods</h3><p>Nationwide cross-sectional multicenter study based on an online survey disseminated in 2022 to physicians invested with preventive healthcare missions.</p></div><div><h3>Results</h3><p>A total of 341 physicians (96% graduates, 32% infectious disease specialists), participated in the survey, with a median age of 40 [35–51] years. On-site access to infection prevention consultations for ICP was reported by 30%, dedicated pre-travel consultations for ICPs by 29%, consultations for infection prevention in solid organ transplant candidates by 16% and return-to-work consultations for ICPs by 6%. Most participants (73%) were aware of nationwide vaccination guidelines for ICP, while 50% felt comfortable using them. Tools for infection prevention advice and ICP vaccination had been developed by 10%, while 89% would have appreciated access to tools developed by others.</p></div><div><h3>Conclusions</h3><p>Infection prevention for ICPs remains neglected. Guidelines covering all fields of prevention for ICPs would be more than welcome.</p></div>","PeriodicalId":13539,"journal":{"name":"Infectious diseases now","volume":"54 2","pages":"Article 104863"},"PeriodicalIF":2.9000,"publicationDate":"2024-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666991924000186/pdfft?md5=74fa29acbe7c3ae2ea217f07b4970822&pid=1-s2.0-S2666991924000186-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Infection prevention for immunocompromised patients: A cross-translational multicentric survey of current organization in France\",\"authors\":\"A. Saade , B. Wyplosz , M. Baldeyrou , C. Paris , P. Tattevin , C. Janssen , for the SPILF group “Vaccination et Prévention”\",\"doi\":\"10.1016/j.idnow.2024.104863\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><p>To evaluate current organization of infection prevention for immunocompromised patients (ICP) at a countrywide level.</p></div><div><h3>Methods</h3><p>Nationwide cross-sectional multicenter study based on an online survey disseminated in 2022 to physicians invested with preventive healthcare missions.</p></div><div><h3>Results</h3><p>A total of 341 physicians (96% graduates, 32% infectious disease specialists), participated in the survey, with a median age of 40 [35–51] years. On-site access to infection prevention consultations for ICP was reported by 30%, dedicated pre-travel consultations for ICPs by 29%, consultations for infection prevention in solid organ transplant candidates by 16% and return-to-work consultations for ICPs by 6%. Most participants (73%) were aware of nationwide vaccination guidelines for ICP, while 50% felt comfortable using them. Tools for infection prevention advice and ICP vaccination had been developed by 10%, while 89% would have appreciated access to tools developed by others.</p></div><div><h3>Conclusions</h3><p>Infection prevention for ICPs remains neglected. Guidelines covering all fields of prevention for ICPs would be more than welcome.</p></div>\",\"PeriodicalId\":13539,\"journal\":{\"name\":\"Infectious diseases now\",\"volume\":\"54 2\",\"pages\":\"Article 104863\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2024-02-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2666991924000186/pdfft?md5=74fa29acbe7c3ae2ea217f07b4970822&pid=1-s2.0-S2666991924000186-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Infectious diseases now\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2666991924000186\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious diseases now","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666991924000186","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

摘要

目的评估目前全国范围内免疫功能低下患者（ICP）感染预防工作的组织情况：方法：基于 2022 年发布的在线调查，在全国范围内开展横断面多中心研究：共有 341 名医生（96% 为毕业生，32% 为传染病专家）参与调查，中位年龄为 40 [35-51] 岁。30%的受访者表示可在现场获得 ICP 感染预防咨询，29%的受访者表示可在旅行前获得 ICP 专门咨询，16%的受访者表示可在实体器官移植候选者中获得感染预防咨询，6%的受访者表示可在重返工作岗位后获得 ICP 咨询。大多数参与者（73%）了解全国范围内的 ICP 疫苗接种指南，50% 的参与者认为可以放心使用。10%的参与者开发了预防感染建议和 ICP 疫苗接种工具，89%的参与者希望获得他人开发的工具：结论：ICP 的感染预防仍被忽视。涵盖 ICP 预防所有领域的指南将大受欢迎。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Infection prevention for immunocompromised patients: A cross-translational multicentric survey of current organization in France

Objectives

To evaluate current organization of infection prevention for immunocompromised patients (ICP) at a countrywide level.

Methods

Nationwide cross-sectional multicenter study based on an online survey disseminated in 2022 to physicians invested with preventive healthcare missions.

Results

A total of 341 physicians (96% graduates, 32% infectious disease specialists), participated in the survey, with a median age of 40 [35–51] years. On-site access to infection prevention consultations for ICP was reported by 30%, dedicated pre-travel consultations for ICPs by 29%, consultations for infection prevention in solid organ transplant candidates by 16% and return-to-work consultations for ICPs by 6%. Most participants (73%) were aware of nationwide vaccination guidelines for ICP, while 50% felt comfortable using them. Tools for infection prevention advice and ICP vaccination had been developed by 10%, while 89% would have appreciated access to tools developed by others.